Baltimore Capital Management’s Merck MRK Stock Holding History

Baltimore Capital Management’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$392K	Buy	+4,934	New	+$369K	0.63%	46
2018 Q3	$341K	Hold	5,039	–	–	0.55%	51
2018 Q2	$292K	Sell	5,039 -209	-4%	-$11.8K	0.43%	57
2018 Q1	$273K	Hold	5,248	–	–	0.41%	59
2017 Q4	$282K	Hold	5,248	–	–	0.4%	61
2017 Q3	$321K	Hold	5,248	–	–	0.45%	54
2017 Q2	$321K	Sell	5,248 -105	-2%	-$6.39K	0.46%	52
2017 Q1	$325K	Buy	+5,353	New	+$325K	0.43%	52

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Baltimore Capital Management's MRK Position: Q1 2019 in Review

Baltimore Capital Management opened a new position in Merck (MRK) in Q1 2019: 4,934 shares worth $392K. The stake represents 0.63% of the portfolio and ranks #46 among its holdings. This is a return to the name: Baltimore Capital Management previously reported a position in MRK as recently as Q3 2018.

Baltimore Capital Management first reported a position in MRK in Q1 2017 and has held it in 8 quarters since. 2,292 funds tracked by Wall St. Rank hold MRK as of Q1 2019.

Baltimore Capital Management held 4,934 shares of Merck worth $392K as of Q1 2019.
Merck was a new Baltimore Capital Management position in Q1 2019.
Merck made up 0.63% of Baltimore Capital Management's portfolio in Q1 2019, its #46 holding.
Baltimore Capital Management first reported a position in Merck in Q1 2017 and has held it in 8 quarters since.
2,292 funds tracked by Wall St. Rank held Merck as of Q1 2019.

Based on Baltimore Capital Management's 13F filing for Q1 2019, filed 14 May 2019.